Page last updated: 2024-08-26

indium and Mast-Cell Sarcoma

indium has been researched along with Mast-Cell Sarcoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brunda, MJ; Gorelik, E; Herberman, RB; Holden, HT; Wiltrout, RH1
Adams, DO; Mastin, JP; Somers, SD1
Cummings, GD; Frost, P; Wiltrout, RH1

Other Studies

3 other study(ies) available for indium and Mast-Cell Sarcoma

ArticleYear
Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.
    Cancer immunology, immunotherapy : CII, 1983, Volume: 14, Issue:3

    Topics: Animals; Chromium; Chromium Radioisotopes; Female; Hydroxyquinolines; Idoxuridine; Immunity, Innate; Indium; Iodine Radioisotopes; Lymphocytes; Lymphoma; Mast-Cell Sarcoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Organometallic Compounds; Oxyquinoline; Radioisotopes; T-Lymphocytes; Tissue Distribution

1983
The binding of tumor cells by murine mononuclear phagocytes can be divided into two qualitatively distinct types.
    Journal of immunology (Baltimore, Md. : 1950), 1983, Volume: 131, Issue:4

    Topics: Animals; Binding Sites; Binding, Competitive; Cell Transformation, Neoplastic; Edetic Acid; Indium; Macrophage Activation; Macrophages; Mast-Cell Sarcoma; Mice; Mice, Inbred A; Mice, Inbred C57BL; Radioisotopes; Trypsin

1983
Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays.
    Journal of the National Cancer Institute, 1978, Volume: 61, Issue:1

    Topics: Animals; Cell Line; Chromium Radioisotopes; Cytotoxicity Tests, Immunologic; Female; Indium; Kinetics; Mast-Cell Sarcoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Radioisotopes; Sarcoma, Experimental; Time Factors

1978